Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BKK:JSP's 5-Year Yield-on-Cost % is ranked better than 71.9% of 1160
companies
in the Consumer Packaged Goods industry
Industry Median: 3.41
vs BKK:JSP: 5.81
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
JSP Pharmaceutical Manufacturing (Thailand) PCL 5-Year Yield-on-Cost % Related Terms
BKK:JSP vs KHC, GIS: 5-Year Yield-on-Cost % Comparison
For the Packaged Foods subindustry, JSP Pharmaceutical Manufacturing (Thailand) PCL's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JSP Pharmaceutical Manufacturing (Thailand) PCL 5-Year Yield-on-Cost % vs Consumer Packaged Goods Industry
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) has a 5-Year Yield-on-Cost % of 5.81 as of Aug. 17, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on JSP Pharmaceutical Manufacturing (Thailand) PCL and its competitors. This is 238% above median its historical median of 1.72. Over the past decade, JSP Pharmaceutical Manufacturing (Thailand) PCL's 5-Year Yield-on-Cost % has ranged from 0.27 to 5.81. According to the industry distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #326 out of 1160 companies in the Consumer Packaged Goods industry, placing it in the top 28.1%.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL's 5-Year Yield-on-Cost % too high?
JSP Pharmaceutical Manufacturing (Thailand) PCL's current 5-Year Yield-on-Cost % of 5.81 is 238% above median its 10-year median of 1.72. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 5.81. The Consumer Packaged Goods industry median 5-Year Yield-on-Cost % is 3.41. JSP Pharmaceutical Manufacturing (Thailand) PCL's value of 5.81 is 70.4% above this industry median. Based on the distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #326 out of 1160 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, JSP Pharmaceutical Manufacturing (Thailand) PCL has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JSP Pharmaceutical Manufacturing (Thailand) PCL's 5-Year Yield-on-Cost % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #326 out of 1160 companies for 5-Year Yield-on-Cost %. This puts JSP Pharmaceutical Manufacturing (Thailand) PCL in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 3.41. JSP Pharmaceutical Manufacturing (Thailand) PCL's value of 5.81 is 70.4% above this benchmark. Historically, JSP Pharmaceutical Manufacturing (Thailand) PCL's own 5-Year Yield-on-Cost % has ranged from 0.27 to 5.81 over the past decade. While the company's 10-year median is 1.72 vs. the industry median of 3.41, JSP Pharmaceutical Manufacturing (Thailand) PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Consumer Packaged Goods company?
The median 5-Year Yield-on-Cost % among Consumer Packaged Goods companies is 3.41, based on 1,160 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JSP Pharmaceutical Manufacturing (Thailand) PCL's current 5-Year Yield-on-Cost % of 5.81 is 70.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on JSP Pharmaceutical Manufacturing (Thailand) PCL and its competitors. For the Consumer Packaged Goods industry, the median 5-Year Yield-on-Cost % is 3.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JSP Pharmaceutical Manufacturing (Thailand) PCL's current 5-Year Yield-on-Cost % is 5.81, which is 238% above median its own 10-year median of 1.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL stock overvalued right now?
Based on GuruFocus' analysis, JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿3.21, compared to a current price of ฿1.72 — trading 46.4% below its estimated fair value. The current 5-Year Yield-on-Cost % is 5.81, which is 238% above median its 10-year median of 1.72 and 70.4% above the Consumer Packaged Goods industry median of 3.41. JSP Pharmaceutical Manufacturing (Thailand) PCL's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP), the current 5-Year Yield-on-Cost % is 5.81 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) Overvalued in 2026?
Based on GuruFocus' analysis, JSP Pharmaceutical Manufacturing (Thailand) PCL stock appears to be undervalued.
The current stock price of ฿1.72 is trading 46.4% below its estimated GF Value™ of ฿3.21.
GuruFocus considers JSP Pharmaceutical Manufacturing (Thailand) PCL to be Significantly Undervalued.
Key valuation signals for BKK:JSP:
5-Year Yield-on-Cost %: 5.81 (238% above median its 10-year median of 1.72)
GF Value™: ฿3.21 vs. price of ฿1.72 (46.4% below fair value)
Industry Position: 70.4% above the Consumer Packaged Goods median (#326 of 1160)
No single metric tells the full story. See the BKK:JSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing modern medicine, traditional medicine, herbal products, dietary supplements, medical supplies, and cleaning alcohol under the client's and the company's own trademarks. Maximum revenue for the company is generated from the sale of dietary supplements. The Group's reportable operating segments are: Manufacture and distribution of products under the company's brand name (Own brands), which generate maximum revenue, Manufacture and distribution of products under customers' brand name (OEM), Manufacture and distribution of hemodialysis solution and related medical supplies; and Service, research and development, and healthcare products training. Geographically, it operates principally in Thailand.
78GF Score
Get the complete analysis for BKK:JSP
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:JSP has been successfully added to your 
